Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease

Study Overview

The researchers are doing this study to learn if a new type of transplant is safe and effective to treat Severe Sickle Cell Disease (SCD).

Study Description

This study is being done to learn if a new type of allogeneic transplant called a haploidentical transplant is safe and effective to treat Sickle Cell Disease (SCD).

Additional Information

Participants will be compensated for their participation.

  • IRB Number: 1711207951 (BMTCTN1507)
  • Research Study Identifier: TX8873
  • Principal Investigator: Sherif Farag, MD

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at or by phone at (888) 264-0005.